Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Patient plan: look up a medication list

PHENOBARBITAL

All products: general benefit

Phenobarb Elixir · DIN 00645575 · 5mg/mL · Oral Elixir

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
No interchangeable product listed in the Ontario extract
Phenobarb Elixir · DIN 00645575 Manufacturer: Pendopharm, Division of Pharmascience Inc.; listing date 2018-01-31 Health Canada: Marketed since 2012-03-05 · brand PHENOBARB ELIXIR · ATC N03AA02 PHENOBARBITAL, N03AA02 PHENOBARBITAL · form Solution · route Oral · ingredients PHENOBARBITAL 5 MG/ML · company Pendopharm division of pharmascience inc · schedule Controlled drugs (cdsa iv)
Check this DIN again · Health Canada product record

Phenobarb Elixir: Formulary list price $0.1535/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.1535 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=6095 · Verify on the e-Formulary ↗ (DIN 00645575)

Source record
DIN 00645575: Phenobarb Elixir Raw flags: sec3=Y Item: 282400235; group id 527; item number 1424; lccId None; manufacturer id PEN Source form: Oral Elixir; strength: 5mg/mL Recorded listing: General benefit Source prices (unrounded): $0.1535; ministry $0.1535 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=00645575 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=6095
Shortage status: resolved shortage (ended 2024-12-10); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00645575
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Other drugs in the same formulary class (28:24 Sedatives and Hypnotics) and how they are covered

Matched class: 28:24 Sedatives and Hypnotics

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: NITRAZEPAM, TEMAZEPAM Some products covered without a code (check the product listing): BUSPIRONE HYDROCHLORIDE, FLURAZEPAM, METHOTRIMEPRAZINE, TRIAZOLAM 28:24 Sedatives and Hypnotics

BUSPIRONE HYDROCHLORIDE

· 9 products · Listed, not a benefit (1), General benefit (8) · strengths: 10mg · Tab

FLURAZEPAM

· 4 products · Listed, not a benefit (2), General benefit (2) · strengths: 15mg, 30mg · Cap

METHOTRIMEPRAZINE

· 9 products · General benefit (5), Listed, not a benefit (4) · strengths: 25mg/mL, 2mg, 5mg, 25mg, 50mg · Inj Sol-1mL Pk, Tab

NITRAZEPAM

· 2 products · General benefit · strengths: 5mg, 10mg · Tab

TEMAZEPAM

· 2 products · General benefit · strengths: 15mg, 30mg · Cap

TRIAZOLAM

· 4 products · Listed, not a benefit (2), General benefit (2) · strengths: 0.125mg, 0.25mg · Tab

LORAZEPAM

· 9 products · Listed, not a benefit (1), Limited Use, codes 481 (2), Off-Formulary Interchangeable, not an ODB benefit (6) · strengths: 4mg/mL, 0.5mg, 1mg, 2mg · Inj Sol (with preservative), SL Tab

MIDAZOLAM

· 3 products · Listed, not a benefit (1), Limited Use, codes 495, 496 (2) · strengths: 5mg/mL · Inj Sol (with Preservative)

ESZOPICLONE

· 6 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 1mg, 2mg, 3mg · Tab

ZOLPIDEM TARTRATE

· 10 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 5mg, 10mg · SL Tab

ZOPICLONE

· 40 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 3.75mg, 5mg, 7.5mg · Tab Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 28:24
Full class listing Related classes: 28:08 Analgesics, 28:10 Opiate Antagonists, 28:12 Anticonvulsants, 28:16 Psychotherapeutic Agents, 28:20 C.N.S. Stimulants, 28:36 Antiparkinsonian Agents, 28:92 Miscellaneous Central Nervous System Drugs Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
INDICATIONS As a sedative, for the relief of anxiety, tension and apprehension. As a hypnotic, for the short-term management of insomnia. As an anticonvulsant, for the long-term treatment of generalized tonicoclonic and partial (cortical focal) seizures. As prophylaxis and treatment of febrile seizures. As an antihyperbilirubinemic, for the prevention and treatment of hyperbilirubinemia in neonates, also to lower bilirubin concentrations in patients with congenital non-hemolytic unconjugated hyperbilirubinemia or chronic intrahepatic cholestasis. https://pdf.hres.ca/dpd_pm/00085981.PDF PM date: SEP 04, 2026 Source product: PMS-PHENOBARBITAL; DIN 00178799; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.